Research output per year
Research output per year
Personal profile
Headline
ASSOCIATE PROFESSOR | Surgery
Fingerprint
Dive into the research topics where Elisa Port is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
Shepherd, J. H., Ballman, K., Polley, M. Y. C., Campbell, J. D., Fan, C., Selitsky, S., Fernandez-Martinez, A., Parker, J. S., Hoadley, K. A., Hu, Z., Li, Y., Soloway, M. G., Spears, P. A., Singh, B., Tolaney, S. M., Somlo, G., Port, E. R., Ma, C., Kuzma, C. & Mamounas, E. & 11 others, , 20 Apr 2022, In: Journal of Clinical Oncology. 40, 12, p. 1323-1334 12 p.Research output: Contribution to journal › Article › peer-review
Open Access78 Scopus citations -
Surgery No More? Managing the Primary Tumor in Stage IV Breast Cancer
Anderson, D. N. & Port, E. R., 20 Mar 2022, In: Journal of Clinical Oncology. 40, 9, p. 927-931 5 p.Research output: Contribution to journal › Article › peer-review
-
Lymphedema precautions: Time to abandon old practices?
Ahn, S. & Port, E. R., 1 Mar 2016, In: Journal of Clinical Oncology. 34, 7, p. 655-658 4 p.Research output: Contribution to journal › Article › peer-review
27 Scopus citations -
Reply to A. Gomberawalla et al and J. Nudelman
Ahn, S. & Port, E. R., 1 Sep 2016, In: Journal of Clinical Oncology. 34, 25, p. 3110-3111 2 p.Research output: Contribution to journal › Letter › peer-review
3 Scopus citations -
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
Sikov, W. M., Berry, D. A., Perou, C. M., Singh, B., Cirrincione, C. T., Tolaney, S. M., Kuzma, C. S., Pluard, T. J., Somlo, G., Port, E. R., Golshan, M., Bellon, J. R., Collyar, D., Hahn, O. M., Carey, L. A., Hudis, C. A. & Winer, E. P., 1 Jan 2015, In: Journal of Clinical Oncology. 33, 1, p. 13-21 9 p.Research output: Contribution to journal › Article › peer-review
Open Access798 Scopus citations
Press/Media
-
Actress Olivia Munn credits breast cancer risk-assessment score for saving her life
14/03/24 → 15/03/24
7 items of Media coverage
Press/Media
-
What women can learn from Olivia Munn's breast cancer diagnosis
14/03/24
5 items of Media coverage
Press/Media
-
Olivia Munn says a breast cancer risk assessment tool helped lead to her diagnosis. Experts explain what to know.
14/03/24
1 item of Media coverage
Press/Media
-
Insulin Resistance and Racial Disparities in BC Prognosis
Bickell, N., Port, E., Gallagher, E. & LeRoith, D.
20/04/22
1 item of Media coverage
Press/Media
-
Insulin Resistance and Racial Disparities in BC Prognosis
Bickell, N., Port, E., Gallagher, E. & LeRoith, D.
28/09/20
1 item of Media coverage
Press/Media